Nadolol is a nonselective β-blocker and an inverse agonist, which is approved by the US Food and Drug Administration (FDA) for managing hypertension and angina. These 2 conditions are major risk factors associated with various cardiovascular diseases, including coronary artery disease, heart failure, and stroke. The drug’s pivotal role in these conditions improves patient outcomes and helps mitigate the progression of cardiovascular disease. In addition to its FDA-approved indications, nadolol proves beneficial in various off-label uses, including the treatment of atrial fibrillation, ventricular arrhythmias linked to long QT syndrome, ventricular premature beats, catecholaminergic polymorphic ventricular tachycardia, supraventricular tachycardia, prophylaxis against gastroesophageal variceal hemorrhage in liver cirrhosis, thyrotoxicosis management, as well as migraine and vascular headache prophylaxis. This activity reviews indications for nadolol, elucidates its mechanism of action, explores adverse drug reactions and toxicity profiles, delineates management strategies and contraindications, and provides a comprehensive understanding of nadolol’s multifaceted role in addressing hypertension, angina, and related conditions. This activity explores nadolol’s pharmacological nuances and clinical applications, empowering interprofessional healthcare providers with the expertise to utilize its therapeutic potential effectively in diverse cardiovascular scenarios.
- Provider:StatPearls, LLC
- Activity Link: https://www.statpearls.com/ArticleLibrary/viewarticle/31524
- Start Date: 2023-09-01 05:00:00
- End Date: 2023-09-01 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
Nursing: 1.0 hours
Pharmacy: 1.0 hours - MOC Credit Details: ABS - 1.0 Point; Credit Type(s): Accredited CME (ABS)
ABPATH - 1.0 Point; Credit Type(s): Lifelong Learning (ABPATH)
ABA - 1.0 Point; Credit Type(s): Lifelong Learning (ABA)
ABTS - 1.0 Point; Credit Type(s): Accredited CME (ABTS)
ABIM - 1.0 Point; Credit Type(s): Medical Knowledge (ABIM)
ABS - 1.0 Point; Credit Type(s): Self-Assessment (ABS)
ABP - 1.0 Point; Credit Type(s): Lifelong Learning and Self-Assessment (ABP)
ABTS - 1.0 Point; Credit Type(s): Self-Assessment (ABTS) - Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Variable
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Adolescent Medicine, Adult Cardiac, Ambulatory/Outpatient, Cardiac Anesthesia, Cardiothoracic, Cardiovascular, Cardiovascular Disease, Chemical Pathology, Clinical Cardiac Electrophysiology, Congenital Cardiac, Critical Care, Critical Care Medicine, Endocrinology, Diabetes, and Metabolism, Gastroenterology, General Operative Anesthesia, General Pediatrics, General Surgery, General Thoracic, Geriatric Medicine, Hospital Medicine, Internal Medicine, Interventional Cardiology, Medical Toxicology, Neurocritical Care, Non-Thoracic Surgery, Pediatric Cardiology, Pediatric Critical Care Medicine, Pediatric Emergency Medicine, Pediatric Endocrinology, Pediatric Transplant Hepatology, Pulmonary Disease, Sports Medicine, Surgical Critical Care, Transplant Hepatology, Vascular Surgery